Items tagged with Prevention

Cipla launches Q-TIB globally (post)

Cipla launches Q-TIB globally, a novel fixed dose combination in a single tablet for TB prophylaxis in HIV.

Flu vaccine may reduce risk for TB (post)

Influenza vaccination may also protect people against tuberculosis, the world’s No. 1 infectious disease killer, according to results from a large nationwide cohort study in Taiwan.

A new way to fight the spread of infectious diseases (post)

An algorithm developed by USC researchers could help public health programs better locate, and treat, people living with undiagnosed infectious diseases, says a new study.

Study indicates that acting on guidelines could avert half of TB cases among children (post)

Tracing contacts of people confirmed to be sick with tuberculosis and making preventive treatment available to those at risk for the disease, could halve current numbers of TB cases among children in resource limited settings, according to researchers reporting a study of patients across a Kenya rural province.

Demographics can help identify migrants to Canada at high risk of TB (post)

Demographic characteristics can help identify groups of immigrants in Canada at high risk of tuberculosis (TB), according to new research in CMAJ (Canadian Medical Association Journal).

Preventive TB therapy during pregnancy causes excessive adverse events (post)

BOSTON — Researchers reported that the immediate initiation of isoniazid preventive therapy for tuberculosis during pregnancy produced an unexpectedly high incidence rate of severe treatment-related adverse events among women with HIV. However, they said the rate was comparable to that among women who initiated therapy postpartum, suggesting that women should be given a choice of when to initiate therapy.

Is an increased risk of getting TB related to vitamin E deficiency? (post)

Researchers in Peru investigate whether there is a link between pre-existing vitamin E status and the likelihood of developing tuberculosis.

How prison conditions fuel the TB epidemic (post)

Dozens of men crammed into a small, dark, window-less prison cell, peering out from the barred doorway, pleading looks on their sweaty faces. In a week-long research trip to Haiti in 2016, a colleague and I toured the largest prison in Port-au-Prince, and this is the image I cannot forget.

Hepatitis B or raised liver enzymes predict liver toxicity when TB prevention drug is combined with HIV treatment (post)

The risk of liver toxicity in people with HIV taking antiretroviral therapy and isoniazid preventive therapy for tuberculosis is strongly associated with either hepatitis B co-infection or pre-existing liver enzyme elevations, according to international research published in the 1 May edition of the Journal of Acquired Immune Deficiency Syndromes.

Price cut on medicine will help preserve the health of more people living with HIV (post)

Geneva, 08 June 2018 — Unitaid and Indian drug manufacturer Cipla Ltd. struck a landmark agreement today that will lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in people living with HIV.

Page 3 of 18 · Total posts: 0

←First 2 3 4 Last→